Partnership with GO-TO and Equity Raising Presentation
BWX
FY22 outlook
•
The Group continues to closely monitor external conditions with key BWX markets and regions remaining at varying stages of the COVID-19 pandemic recovery
In Australia, the Group has experienced some variability to sales as a result of state based COVID 19 restrictions
In North America, 2H21 performance showed encouraging signs of recovery vs 1H21, however the 1H22 performance remains subject to the COVID-19 situation in
this region which remains uncertain
Notwithstanding the near-term uncertainty, the Group expects FY22 to benefit from:
Full year contribution from Woolworths, which commenced in 2H21;
Full year contribution from Flora & Fauna;
Continued strong performance of the Group's direct-to-consumer operations;
Full year benefits from the Chemist Warehouse Strategic Partnership; and
Recent distribution gains achieved in key retail channels
As the natural category continues to gain momentum and attract more consumers, BWX is ideally placed to benefit from and accelerate this trend with important
investments made in our brands and manufacturing capability
STRICTLY CONFIDENTIAL
Notes: 1. Pro forma FY21 revenue including Go-To and Flora & Fauna.
36View entire presentation